PROF
Profound Medical Corp.Company Information
- Company Name
- Profound Medical Corp.
- CIK
- CIK0001628808
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PROF: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- PROF
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-05-16
- Last sale
- —
- Shares purchased (TTM)
- 12,027
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 16,064,630
- Shares outstanding
- 36,350,665
- Ownership
- 44.19%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -13.73%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | 38 | 50 | 60 | 25 | 35 | 46 | 55 | ||||||
| Accounts And Other Receivables Net Current | 10 | 9 | 7 | 8 | 5 | 6 | 7 | ||||||
| Inventory Net | 10 | 9 | 8 | 8 | 8 | 7 | 6 | ||||||
| Assets Current | 59 | 70 | 76 | 42 | 49 | 60 | 69 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 3 | 3 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Tax Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 62 | 73 | 77 | 42 | 50 | 61 | 70 | ||||||
Liabilities Current | |||||||||||||
| Accounts Payable Current | 1 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities And Other Liabilities | 3 | 3 | 4 | 4 | 4 | 3 | 3 | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 0 | 1 | 1 | 0 | ||||||
| Long Term Debt Current | 5 | 5 | 4 | 4 | 4 | 4 | 2 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Taxes Payable Current | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Liabilities Current | 9 | 11 | 6 | 10 | 6 | 5 | 7 | ||||||
| Contract With Customer Liability Noncurrent | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | 3 | 3 | - | - | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 13 | 14 | 11 | 10 | 10 | 10 | 10 | ||||||
Stockholders Equity | |||||||||||||
| Common Stock Value | 325 | 324 | 324 | 283 | 282 | 282 | 282 | ||||||
| Additional Paid In Capital | 26 | 26 | 25 | 24 | 24 | 22 | 21 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 3 | 4 | 5 | 5 | 6 | 3 | 3 | ||||||
| Retained Earnings Accumulated Deficit | -304 | -295 | -288 | -280 | -272 | -256 | -245 | ||||||
| Stockholders Equity | 50 | 59 | 66 | 32 | 39 | 51 | 60 | ||||||
| Liabilities And Stockholders Equity | 62 | 73 | 77 | 42 | 50 | 61 | 70 | ||||||
| Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Issued | 37 | 36 | 36 | 30 | 30 | 30 | 30 | ||||||
| Shares Outstanding | 37 | 36 | 36 | 30 | 30 | 30 | 30 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialProfound Medical Corp. (PROF) — SEC Financial Statements & Analysis
Profound Medical Corp. (PROF) is a surgical & medical instruments & apparatus company, incorporated in A6. Profound Medical Corp. trades on Nasdaq as: PROF. Profound Medical Corp. (PROF)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Profound Medical Corp. carries a market cap of $241.73M, a P/E ratio of 7.38x, a P/B ratio of 4.85x, a P/S ratio of 12.67x, an enterprise value of $207.97M, and an EV/EBITDA multiple of 5.82x. On profitability, it posts a gross margin of 71.79%, an operating margin of 185.31%, a net margin of 171.56%, a Return on Equity (ROE) of 73.53%, a Return on Assets (ROA) of 58.44%, and a Return on Invested Capital (ROIC) of 281.52%. Per share, it reports EPS of $0.90, diluted EPS of $0.90, free cash flow per share of $-0.99, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 6.46x, a quick ratio of 5.31x, working capital of $49.75M, a debt-to-equity ratio of 0.25x, a debt ratio of 0.2, an interest coverage ratio of 35.55x, free cash flow of $-36.10M (TTM), and net debt of $-33.76M. Figures sourced from SEC EDGAR.
- Market Cap
- $241.73M
- P/E TTM
- 7.38x
- EPS TTM
- $0.90
- P/B TTM
- 4.85x
- ROE TTM
- 73.53%
- ROA TTM
- 58.44%
- Debt To Equity
- 0.25x
- Free Cash Flow TTM
- $-36.10M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Profound Medical Corp. in?
Profound Medical Corp. (PROF) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does PROF trade on?
Profound Medical Corp. (PROF) trades on the Nasdaq.
Where is Profound Medical Corp. incorporated?
Profound Medical Corp. is incorporated in Ontario, Canada.
When was Profound Medical Corp. (PROF)'s most recent SEC filing?
Profound Medical Corp. (PROF)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is PROF's market cap?
Profound Medical Corp. (PROF) has a market capitalization of $241.73M as of 2026-06-30.
What is PROF's P/E ratio?
Profound Medical Corp. (PROF)'s trailing twelve month P/E ratio is 7.38x as of 2026-06-30.
What is PROF's EPS (earnings per share)?
Profound Medical Corp. (PROF)'s trailing twelve month EPS is $0.90 as of 2026-06-30.
What is PROF's ROE (return on equity)?
Profound Medical Corp. (PROF)'s trailing twelve month Return on Equity (ROE) is 73.53% as of 2026-06-30.
What is PROF's ROA (return on assets)?
Profound Medical Corp. (PROF)'s trailing twelve month Return on Assets (ROA) is 58.44% as of 2026-06-30.
What is PROF's ROIC (return on invested capital)?
Profound Medical Corp. (PROF)'s trailing twelve month Return on Invested Capital (ROIC) is 281.52% as of 2026-06-30.
What is PROF's EV/EBITDA?
Profound Medical Corp. (PROF)'s trailing twelve month EV/EBITDA is 5.82x as of 2026-06-30.